Sofosbuvir and velpatasvir with or without voxilaprevir in direct-acting antiviral-naïve chronic hepatitis C: patient-reported outcomes from POLARIS 2 and 3.

Younossi, Z M; Stepanova, M; Jacobson, I M; Asselah, T; Gane, E J; Lawitz, E; Foster, G R; Roberts, S K; Thompson, A J; Willems, B E; Welzel, T M; Pearlman, B; Younossi, I; Racila, A; Henry, L

Younossi, Z M; Stepanova, M; Jacobson, I M; Asselah, T; Gane, E J; Lawitz, E; Foster, G R; Roberts, S K; Thompson, A J; Willems, B E; Welzel, T M; Pearlman, B; Younossi, I; Racila, A; Henry, L.

Affiliation

Younossi ZM; Falls Church, VA, USA.
Stepanova M; Washington, DC, USA.
Jacobson IM; New York, NY, USA.
Asselah T; Clichy, France.
Gane EJ; Auckland, New Zealand.
Lawitz E; San Antonio, TX, USA.
Foster GR; London, UK.
Roberts SK; Victoria, Australia.
Thompson AJ; Victoria, Australia.
Willems BE; Montréal, Québec, Canada.
Welzel TM; Frankfurt am Main, Germany.
Pearlman B; Atlanta, GA, USA.
Younossi I; Washington, DC, USA.
Racila A; Falls Church, VA, USA.
Henry L; Washington, DC, USA.

Aliment Pharmacol Ther ; 47(2): 259-267, 2018 01.

Article in En | MEDLINE | ID: mdl-29181842

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Sulfonamides / Carbamates / Hepatitis C, Chronic / Macrocyclic Compounds / Sofosbuvir / Heterocyclic Compounds, 4 or More Rings Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2018 Document type: Article Affiliation country: Country of publication:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google